Skip to main content
Earnings Labs
UP

Upstream Bio, Inc. (UPB)

NASDAQ·Healthcare·Biotechnology

$3.26

+0.93%

Mkt Cap $176.91M

Analyst Ratings

Buy

3

Hold

2

Sell

0

Price Target (5 analysts)

$25.00

Range $25.00 – $25.00

Implied Upside

+666.9%

Consensus $25.00 vs current $3.26